Results 331 to 340 of about 770,373 (401)

Risk of high‐grade cervical lesions in the second round of primary human papillomavirus testing in CervicalScreen Norway: A population‐based cohort study

open access: yesInternational Journal of Cancer, EarlyView.
What's new? Many countries are transitioning from cytology to human papillomavirus (HPV) testing as the primary cervical cancer screening test. This comprehensive evaluation of the second HPV screening round in CervicalScreen Norway among women returning 4–6 years after a first negative HPV test showed that their risk of testing positive was lower in ...
Tone Bjørge   +5 more
wiley   +1 more source

Therapeutic targeting of chromatin alterations in leukemia and solid tumors

open access: yesInternational Journal of Cancer, EarlyView.
Abstract Alterations in chromatin conformation and post‐translational modification of histones have become increasingly recognized as critical drivers of cancer development, progression, and therapy resistance. Recent advances in drug development have led to the establishment of several highly selective small molecule inhibitors, several of which are ...
Florian Perner   +7 more
wiley   +1 more source

Technical, legal and ethical framework of cancer audit in cervical screening – Summary of best practices for organised programmes delineated through an expert group consultation

open access: yesInternational Journal of Cancer, EarlyView.
What's New? There have been increasing litigations against cervical screening programmes centred around cancer audits. This manuscript provides a comprehensive framework for conducting cancer audits in cervical screening programmes, addressing legal and ethical challenges, and ensuring effective outcomes.
Arunah Chandran   +36 more
wiley   +1 more source

Obstetrics and Gynecology [PDF]

open access: yes, 2009
中島 彰俊   +7 more
core   +1 more source

The transcription factor RIP140 regulates interferon γ signaling in breast cancer

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Interferon γ (IFNγ) is a key player in breast cancer, with the potential to induce apoptosis and to shift tumors into a dormant state. However, it also may promote carcinogenesis and angiogenesis. In this study, transcriptomic analysis identified the transcription factor RIP140 as a key regulator of IFNγ signaling in breast cancer.
Stéphan Jalaguier   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy